Clearside Biomedical Inc.
13F holders, Q3 2025 (September 30)3holders −42
1new positions
24sold out
$3.89avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Clearside Biomedical Inc. in their 13F filings, down 42 from Q2 2025. 1 opened new positions and 24 sold out. The largest holders were Carmignac Gestion ($399K), Apollon Wealth Management, LLC ($47K) and Osaic Holdings, Inc. ($900).
- Company
- Clearside Biomedical Inc.
- CUSIP
- 185063104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $47K |
| Exits | 24 | $733K |
All 13F filers, Q2 2025 → Q3 2025: 11,793 shares bought and 2,325,300 shares sold, net −2,313,507 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Carmignac Gestion | 0.01% | Reduce -93.3% | 100,556 | $399K |
| Apollon Wealth Management, LLC | 0.00% | New | 11,793 | $47K |
| Osaic Holdings, Inc. | 0.00% | Reduce -7.6% | 2,500 | $900 |
"% of holder's portfolio" is CLEARSIDE BIOMEDICAL INC's weight in each manager's 13F, not the share of Clearside Biomedical Inc. the manager owns.